Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

ENTA needs to start acquiring small biotechs.

ENTA doesn’t need to do that, but such a possibility has to at least be considered by investors. There are a few companies with very cheap enterprise values who have pipelines that fit with ENTA’s areas of expertise.

In short, I think an acquisition by ENTA is unlikely, but possible.